goserelin has been researched along with Carcinoma--Intraductal--Noninfiltrating* in 1 studies
1 other study(ies) available for goserelin and Carcinoma--Intraductal--Noninfiltrating
| Article | Year |
|---|---|
A response in advanced post-menopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist--Zoladex.
Luteinising hormone releasing hormone (LHRH) agonists are currently undergoing clinical trials in the treatment of advanced breast cancer in pre-menopausal women. Clinical responses are attributed to the suppression of the pituitary-ovarian axis, with a reduction in circulating levels of gonadal steroids similar to that produced by castration. In the present case report, we report a partial response to a LHRH analogue in a post-menopausal woman refractory to other endocrine treatments. This response cannot be explained with a chemical castration and confirms the possible direct anti-tumor effect of Zoladex. Topics: Aged; Breast Neoplasms; Buserelin; Carcinoma, Intraductal, Noninfiltrating; Female; Goserelin; Humans; Menopause | 1989 |